F049 Translating Evidence into Practice: Atopic Dermatitis Guidelines
DESCRIPTION
This session will focus on recent developments in atopic dermatitis and how they affect our clinical practice. Specific talks will be devoted to deciphering new associations and co-morbidities; understanding the evidence behind newer therapies particularly biologics; and plumbing for clinical pearls that may slip between the cracks of the "evidence."
LEARNING OBJECTIVES
Highlight newest systemic therapy options for atopic dermatitis.
Discuss newest topical therapies for atopic dermatitis and how they fit into therapeutic armamentarium.
Review newer associations and co-morbidities and discuss clinical implications.
SCHEDULE
9:00 AM
Introduction
Robert Sidbury, MD, MPH, FAAD
9:05 AM
Comorbidity Update
Dawn M.R. Davis, MD, FAAD
9:30 AM
Topical Therapy
Lawrence F Eichenfield, MD, FAAD
10:00 AM
Systemic Therapy
David Eric Cohen, MD, FAAD
10:30 AM
The Rest of the Story
Robert Sidbury, MD, MPH, FAAD
DIRECTOR
Robert Sidbury, MD, MPH, FAAD
SPEAKERS
David Eric Cohen, MD, FAAD
Dawn M.R. Davis, MD, FAAD
Lawrence F Eichenfield, MD, FAAD
HANDOUTS
DISCLOSURES
David Eric Cohen, MD, FAAD
Cosmetic Ingredient Review – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Dualitas Therapeutics – Consultant (1099 relationship)(Honoraria); Evommune, Inc. – Board of Directors(Fees), Board of Directors(Stock Options); Facilitation of International Dermatology Education – Consultant(Honoraria); Ferndale Laboratories, Inc. – Consultant(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Consultant(Honoraria); Medimetriks Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Timber Pharmaceuticals – Board of Directors(Fees), Board of Directors(Stock Options); UCB – Consultant(Honoraria);
Dawn M.R. Davis, MD, FAAD
OpenEvidence – Other(Other Financial Benefit); SPARK – Other(Other Financial Benefit);
Lawrence F Eichenfield, MD, FAAD
Abbvie – Investigator(Grants/Research Funding); Abeona Therapeutics – Consultant (1099 relationship)(Honoraria); Acrotech Biopharma Inc – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Consultant (1099 relationship)(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); Kymera Therapeutics – Consultant (1099 relationship)(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Target RWE – Investigator(Grants/Research Funding); TopMD – Consultant(Stock Options); TRex Bio – Consultant (1099 relationship)(Honoraria); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Robert Sidbury, MD, MPH, FAAD
Alphyn Biologics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Advisory Board(Honoraria); Dermavent – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma Global – Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(No Compensation Received);